London, United Kingdom

Maria Thanou

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: King's College London. Active years: 2023.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Maria Thanou: Innovator in Lipid Nanoparticle Technology

Introduction

Maria Thanou is a distinguished inventor based in London, GB. She has made significant contributions to the field of drug delivery systems through her innovative work on lipid nanoparticles. Her research focuses on enhancing the efficacy of drug administration using advanced technologies.

Latest Patents

Maria Thanou holds a patent for her invention related to nanoparticles. The patent describes a drug-containing lipid nanoparticle that can release a drug as a result of focused ultrasound (FUS) applied continuously to a desired part of the body. This method induces hyperthermia, allowing for controlled drug release at the targeted site. The lipid nanoparticles can also be labeled for imaging purposes, enabling real-time monitoring of the drug within the human body.

Career Highlights

Maria Thanou is affiliated with King's College London, where she conducts her research and development work. Her innovative approach to drug delivery has garnered attention in the scientific community, contributing to advancements in medical treatments.

Collaborations

Some of her notable coworkers include Andrew David Miller and Michael James Lee Wright. Their collaborative efforts have furthered the research and application of lipid nanoparticle technology.

Conclusion

Maria Thanou's work in lipid nanoparticle technology represents a significant advancement in drug delivery systems. Her innovative approach has the potential to improve treatment outcomes for patients, showcasing the importance of research and development in the medical field.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…